Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh
Covishield vaccine induces robust immune responses in Bangladeshi adults
Covishield vaccine induces robust immune responses in Bangladeshi adults Read More »
Clinical evaluation of SARS-CoV-2 antigen-based rapid diagnostic test kit for detection of COVID-19 cases in Bangladesh
Genome sequences of 15 SARS-CoV-2 sublineage B. 1.617. 2 strains in Bangladesh.
Genome sequences of 15 SARS-CoV-2 sublineage B. 1.617. 2 strains in Bangladesh. Read More »
Genome Sequences of 25 SARS-CoV-2 Sublineage B.1.1.529 Omicron Strains in Bangladesh
Genome Sequences of 25 SARS-CoV-2 Sublineage B.1.1.529 Omicron Strains in Bangladesh Read More »
Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh